These Analysts Revise Their Forecasts On DexCom Following Q3 Results
Portfolio Pulse from Avi Kapoor
DexCom, Inc. (NASDAQ:DXCM) reported better-than-expected Q3 results, with earnings and revenue surpassing analyst estimates. Despite this, shares fell 1.6%. Several analysts revised their price targets, with mixed adjustments. Additionally, Teri Lawver, EVP and CCO, will retire, with CEO Kevin Sayer temporarily assuming her responsibilities.
October 25, 2024 | 6:58 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
DexCom reported Q3 earnings and revenue that exceeded expectations, but shares fell 1.6%. Analysts revised price targets with mixed changes. EVP Teri Lawver will retire, with CEO Kevin Sayer temporarily taking over her role.
Despite better-than-expected earnings and revenue, DexCom's stock fell, indicating potential investor concerns or profit-taking. Analysts' mixed price target revisions suggest varied expectations for future performance. The retirement of a key executive adds uncertainty, but the CEO's temporary leadership may stabilize operations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100